Drug Trial Radar · NCT04475432
Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Last checked: Nov 20, 2026Latest source record: Dec 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
421
Actual
Start
Sep 9, 2020
Primary completion
May 4, 2021
Study completion May 4, 2021
Sponsor
- Lead sponsor
- Tarsus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the safety and efficacy of TP-03, 0.25%, an eyedrop, to its vehicle control for the treatment of blepharitis due to Demodex, a microscopic mite frequently found in human hair follicles. The hypothesis for the study is the proportion of participants cured at Day 43 with treatment by TP-03, 0.25%, is greater than the proportion cured by treatment with its vehicle.
Conditions
- Blepharitis
Interventions
TP-03, 0.25%Drug
TP-03, lotilaner ophthalmic solution, 0.25%, administered twice a day
TP-03 VehicleDrug
Vehicle of TP-03 ophthalmic solution, administered twice a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants Cured Based on a Collarette Score at Day 43.Time frame: 43 days
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Eye Research Foundation
Newport Beach, California
Visionary Eye Institute
Newport Beach, California
Vision Institute
Colorado Springs, Colorado
Midwest Cornea Associates, LLC
Carmel, Indiana
Washburn Research LLC
Indianapolis, Indiana
The Eye Care Institute
Louisville, Kentucky
Andover Eye Associates
Andover, Massachusetts
Ophthalmology Associates
St Louis, Missouri
Oculus Research, Inc at EyecareCenter
Raleigh, North Carolina
Vita Eye Clinic
Shelby, North Carolina
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Total Eye Care, P.A.
Memphis, Tennessee
Alpine Research Organization
Layton, Utah
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.